DC-PEACETECH-LAB
24.12.2021 11:02:08 CET | Business Wire | Press release
The International Peace Honors (IPH), created by PeaceTech Lab , an award-winning non-profit organization founded by the United States Institute of Peace , will recognize Forest Whitaker, Ajay Banga, Juanes, Tokata Iron Eyes, Brandon Stanton, Dr. Lisa Su and Nicholas Donofrio for being global change-makers who have positively impacted the world through targeted activism. The virtual event airs Sunday, February 27th, 2022, at 8:00 pm EST. To register to watch visit: internationalpeacehonors.org .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211223005439/en/
“This year’s International Peace Honorees inspire us to greater hope and urgency, by showing what can happen when we leverage technology and media in their highest forms. From promoting peace and non-violence through music, to helping people improve their lives through the digital economy, protect the planet, and raise up a generation of new voices, their tireless work for the betterment of humanity is to be lauded. We are thrilled to recognize each of these outstanding social leaders,” said Sheldon Himelfarb , President & CEO, PeaceTech Lab.
Academy Award Winner, Forest Whitaker will receive the recognition for his everlasting commitment to empowering youth and promoting peace globally. Whitaker is the CEO/Founder of the Whitaker Peace & Development Initiative (WPDI), which provides educational tools and economic opportunities to young people in places touched by exclusion, violence and armed conflict.
Mastercard Executive Chairman, Ajay Banga will receive the honor for his outstanding contributions in bringing the digital economy to over 1 billion people, thus creating a sustainable economy through technology.
Renowned Singer-Songwriter and Social Advocate, Juanes will be honored for his dedication to youth empowerment and peace in his native Colombia through his Mi Sangre Foundation , a peace-building non-profit organization he co-founded alongside Catalina Cock Duque.
Youth Activist, Tokata Iron Eyes is set to be honored for her impassioned advocacy for Indigenous rights and the global climate movement. At age 18, she becomes the youngest person to receive the prestigious award.
Brandon Stanton , the creator of “Humans of New York” , will be celebrated for his dedication to fostering empathy and interconnectedness through powerful storytelling.
AMD ’s President and CEO, Dr. Lisa Su , will be recognized for revolutionizing high performance computing, donating supercomputing power for public good efforts focused on infectious disease research, and for inspiring people from all backgrounds to pursue careers in science and technology.
Lastly, former IBM EVP of Innovation and Technology Nicholas Donofrio , will receive the honor for his contributions to the international community of women and underrepresented youth in the fields of education, engineering, business and mathematics.
“The exceptionalism of our honorees reminds us that we’re all capable of rising to the challenges that negatively affect our world. I’m proud to extol their valuable social contributions and celebrate their vast achievements,” added MariaEsmeralda Paguaga , executive producer of the International Peace Honors .
The host, performers, and special guests will be announced in the upcoming weeks.
The International Peace Honors are made possible with the generosity of its sponsors and donors: Mastercard, BNY Mellon, The MITRE Corporation, Microsoft, Pitney Bowes, Liberty Mutual Insurance, Ernst & Young, Mercator XXI, KUDO, Wipro, and Alliance for Peacebuilding.
Follow @internationalpeacehonors for more information.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211223005439/en/
Link:
Social Media:
https://www.facebook.com/peacetechlab/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom